
ECG Stock Forecast & Price Target
ECG Analyst Ratings
Bulls say
Everus Construction Group is viewed positively because its core E&M franchise is benefiting from robust data center demand, a ramp in semiconductor work, and a record $4.55 billion backlog that was up 53% year over year, with management expecting about 80% to convert within 12 months. The company’s recent SE&M acquisition and pending Epsilon deal should expand its footprint, improve access to attractive end markets, and support margin accretion, while still leaving leverage around 0.8x and well below the 1.5x-2.0x target range. Its T&D business adds steadier utility-driven growth, and combined with conservative guidance, improving margins, and a scaled workforce capable of executing large projects, the setup suggests continued upward estimate revisions and durable earnings growth.
Bears say
Everus Construction Group is exposed to meaningful customer concentration, with its two largest E&M customers representing 25% of consolidated revenue in 2025 and the largest T&D customer representing 16% of that segment’s sales, so any slowdown in capital spending could quickly pressure results. Its growth profile also looks uneven because T&D demand is not as aligned with power-generation-heavy themes, while large EPC projects, labor shortages, and geographic concentration can create delays, cost overruns, and quarterly margin volatility. Near-term profitability is further constrained by elevated acquisition-related amortization, the pending Epsilon transaction, and roughly $13 million per quarter of corporate expense, all while the company is still proving itself as a newly independent public company.
This aggregate rating is based on analysts' research of Everus Construction Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.
ECG Analyst Forecast & Price Prediction
Start investing in ECG
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Everus Construction Group, Inc. (ECG) Forecast
ECG Analyst Forecast & Price Prediction
Start investing in ECG
Order type
Buy in
Order amount
Est. shares
0 shares